| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.54 | 0.005 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.46 | 0.006 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.5 | 0.006 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.42 | 0.008 |